/
/
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
JoVE 비디오를 활용하시려면 도서관을 통한 기관 구독이 필요합니다. 전체 비디오를 보시려면 로그인하거나 무료 트라이얼을 시작하세요.
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
1,594 Views
•
09:34 min
•
August 16, 2021
DOI:
1Department of Clinical Medicine, Trinity Translational Medicine Institute, St. James’s Hospital, Trinity College Dublin,The University of Dublin, 2School of Pharmacy and Biomolecular Sciences,Royal College of Surgeons in Ireland (RCSI), 3SFI Advanced Materials and Bioengineering Research (AMBER) Centre,RCSI & TCD, 4SFI Centre for Research in Medical Devices (CURAM), RCSI,Dublin and National University of Ireland
Summary
Automatically generated
Rapid and efficient quantification of intracellular M. tuberculosis growth is crucial for pursuing improved therapies against tuberculosis (TB). This protocol describes a broth-based colorimetric detection assay using an automated liquid culture system to quantify Mtb growth in macrophages treated with candidate host-directed therapies.
Explore More Videos
Automated Culture SystemHost-directed TherapiesTuberculosisMycobacterium TuberculosisIntracellular GrowthFDA-approved DrugsRepurposingMycobacterial CultureEO Carrier T-cell CultureAttenuated Mycobacterial CultureH37RaCentrifugationRPMIResuspensionMycobacterial SuspensionGlass Chamber SlidesPhagocytosisPBSPFA
Read Article
Cite this Article
O’Leary, S., Bahlool, A. Z., O’Connor, G., Cryan, S., Keane, J. M., O’Sullivan, M. P. An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis. J. Vis. Exp. (174), e62838, doi:10.3791/62838 (2021).
Copy